Department of Biotechnology supported efficacy trial with recombinant BCG vaccine, VPM1002 completes…
New Delhi: Serum Institute of India Pvt Ltd (SIIPL) has been supported under Department of Biotechnology’s National Biopharma Mission for conduct of a multisite randomized double-blinded placebo-controlled phase III clinical trial ofa…